EU strengthens infant formula safety after contamination alerts

EU strengthens infant formula safety after contamination alerts

Rating
—/5 0 ratings
Follow us on Google News
Health & Lifestyle8 min read

On 6 November 2026, European Union member states backed a European Commission proposal to introduce a permanent criterion for cereulide in infant formula, follow-on formula and foods for special medical purposes intended for infants. The initiative follows a contamination incident that prompted alerts and product recalls in several countries, including Romania.

What we know now: The EU does not yet have a final, published and applicable rule for finished products. Mandatory controls are already in place for an ingredient linked to the incident—arachidonic acid oil, also known as ARA—while the future rule would add a permanent check for cereulide in formula. This marks a shift from responding through recalls to more predictable controls, but it does not guarantee that every tin will be individually tested.

Infant formula safety: what EU member states backed

In its 6 November communication, the European Commission announced that member states had backed a permanent criterion for cereulide. The substance is a toxin produced by certain Bacillus cereus bacteria and can cause acute vomiting, in particular, after ingestion.

The wording of the announcement matters: backing a proposal through the European procedure is not the same as publishing the regulation in the Official Journal of the European Union. The Commission said the regulation would become applicable 20 days after publication.

On the publicly available EUR-Lex page, the measure still appears as a draft regulation, rather than a final act. The same page gives a planned adoption period of 1 January to 31 March 2027. Until the final version is published, details such as the exact limit, its application to different product types and laboratory requirements should not be presented as rules already in force.

Three distinct elements: the EFSA assessment, ingredient controls and the proposed limit

The incident has produced an overlap of figures and documents that can be confusing. They relate to distinct stages of risk management.

Level What it represents Status at the end of 2026
EFSA assessment A toxicological reference point for acute exposure in infants Completed and used for risk management
Controls on ARA oil from China Increased checks on imports of the ingredient associated with the contamination Mandatory under a published regulation
Criterion for finished formula A limit and sampling plan for products intended for infants Proposed and politically backed; the final act has not yet been published

EFSA established an acute reference dose of 0.014 micrograms of cereulide per kilogram of body weight for infants, using vomiting as the critical acute effect. The assessment also calculated action thresholds for formula, intended to assist authorities during the incident. These action thresholds should not automatically be confused with a permanent legal limit.

The draft legislative act consulted on EUR-Lex proposes, for certain formulas and foods intended for infants, a sampling plan of n=3, c=0 and a value of 0.1 micrograms/kg. In plain terms, n=3 means three samples from the unit being tested, while c=0 means that none of the samples should exceed the criterion. For liquid products, the proposed text includes an adjustment related to reconstitution.

These details show the rule’s technical direction, not its final version. Particularly for infant products, the difference between a public draft and a legal obligation is practical: only the final regulation will establish unambiguously what must be complied with and from when.

One measure is already mandatory: increased controls for ARA oil

Following alerts and investigations in the first months of 2026, the EU had already adopted a measure covering the raw material involved in the supply chain. Implementing Regulation (EU) 2026/459, published on 24 February 2026, introduced special conditions and increased official controls for imports of arachidonic acid oil originating in China.

The regulation sets a 50% frequency for identity and physical checks on the shipments concerned. It links the measure to investigations into contaminated formulas and alerts in the European Rapid Alert System for Food and Feed, RASFF.

This is not the same measure as the future criterion for formula sold to consumers. Import controls address an upstream link, the ARA ingredient. The proposed permanent criterion would check the downstream product, the finished formula. The two levels complement one another: the first may reduce the risk that a problematic ingredient enters the European supply chain, while the second may provide a common benchmark for products reaching the market.

Neither, however, replaces supplier oversight, manufacturing-process hygiene, traceability or the ability to carry out rapid recalls. A microbiological or toxicological criterion does not automatically mean testing every tin of formula, nor does it eliminate every risk before a product reaches a family.

Why the change was needed

The joint ECDC–EFSA assessment of the multinational outbreak recorded infants with gastrointestinal symptoms in six EU member states and the United Kingdom between 19 December 2025 and 13 February 2026. Some cases required hospitalisation for dehydration. The report should be read within its limits: it describes a specific stage of the investigation, not the current clinical situation in every country.

Globally, the World Health Organization said on 13 March 2026 that recalled products had reached 99 countries and territories, and that 144 suspected or confirmed cases had been reported in 10 countries. The WHO stressed at the time that full traceability and root-cause analysis were still under way.

An ingredient used in several formulas and distributed internationally may explain why alerts can spread rapidly across brands and markets. It does not follow, however, that all formula products, all brands or all ingredients in the same category were contaminated. Preventive recalls may include products removed from sale because they share the same raw material or traceability link, without every recalled unit having tested positive.

What is known about Romania—and what cannot be stated

In Romania, batches of Aptamil, Milupa and NAN formula were recalled in February 2026, according to notifications by the National Sanitary Veterinary and Food Safety Authority (ANSVSA) reported by AGERPRES. This confirms that some products covered by precautionary measures were present on the Romanian market.

However, the public sources consulted for this article do not indicate that clinical cases in Romania linked to this incident have been confirmed. Nor does the recall of some batches justify claiming that all formula available in Romania was affected. The distinction matters for parents, pharmacies and retailers alike: an alert should be checked by product, batch, pack size and expiry date, rather than assumptions about an entire brand.

What parents can do if they have formula at home

In the absence of an active alert for a particular product, changing formula solely because of general concern is not recommended. Infant formula has an important nutritional role, and changing it may require discussion with the child’s doctor, especially in cases involving prematurity, allergies, digestive problems or formula used for a special medical purpose.

  • Check whether the product exactly matches an official alert: its name, formula type, pack size, batch number and expiry date.
  • If the batch is included in a recall, do not give the product to the child; follow the retailer’s, manufacturer’s or authority’s instructions on returning it.
  • Keep the tin or container, label and receipt, if available. These can help identify the batch quickly.
  • Do not interpret a targeted recall as confirmation that all similar formulas are unsafe.

Repeated vomiting, refusal to feed, unusual drowsiness, substantially fewer wet nappies, a dry mouth or other signs of dehydration in an infant require prompt medical assessment. In an emergency, or if the child’s condition appears severe, call 112. Digestive symptoms can have many causes; they do not, on their own, establish a link to a food product.

What to watch before the new rule takes effect

The next decisive document will be the final regulation published in the Official Journal of the EU. It will need to confirm the legal limit, the exact product categories covered, rules for powdered and liquid products, the method of application and the date from which operators must comply with the new criterion.

Until then, the useful conclusion is more nuanced than “the EU has solved the problem”. The Union has already put in place an import barrier for an ingredient associated with the incident and is preparing a second barrier for the finished product. Its real effectiveness will still depend on testing, traceability, swift notification of alerts and how clearly recalls reach families with the product at home.

Frequently asked questions

Has the new European cereulide limit for infant formula already taken effect?

No. As of the information consulted, member states had backed the proposal, but the document available on EUR-Lex was still a draft. The rule will become applicable only after the final regulation has been adopted and published in the Official Journal of the EU.

Does a batch recall mean that all formula from the same brand is contaminated?

No. A recall concerns the products and batches identified in the alert. It may be preventive, based on a shared raw material or traceability, and does not demonstrate contamination of every product from the same brand.

What is cereulide?

Cereulide is a toxin associated with certain Bacillus cereus bacteria. In EFSA’s assessment for the 2026 incident, vomiting was the critical acute effect considered in establishing a toxicological reference point for infants.

What should be checked in an infant formula alert?

The exact product name, formula type, pack size, batch number and expiry date. Checking the brand name alone is not enough.

Sources consulted

Etichete: ANSVSACereulideEuropean CommissionEFSAInfant formulaProduct withdrawalsFood safety
Share this article
COMUNITATEA INFOBUZ

Discuția cititorilor

Ai o opinie sau o întrebare despre acest articol? Spune-ne ce crezi.

0 comentarii

Fii primul care deschide discuția.

Lasă un comentariu

Email address este vizibilă doar administratorilor și nu va fi publicată. Câmpurile marcate cu * sunt obligatorii.

Te rugăm să păstrezi un limbaj civilizat și să discuți la subiect. Comentariile spam sunt filtrate automat.